Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02498297

Ligand	Ligand name	Chain	PDB	Tanimoto
DFI	2,2-DIFLUOROSTATINE	E,I	1APW	0.71
LTA	4,8-DIAMINO-3-HYDROXY-OCTANOIC ACID ETHYL ESTER	E,I	1APT	0.76
STA	STATINE	E	1EPP	0.76
STA	STATINE	I	1XN3	0.76
STA	STATINE	A,B,I,J	2FIV	0.76
STA	STATINE	A,B,C,D	1QS8	0.76
STA	STATINE	A,B	2RMP	0.76
STA	STATINE	E,I	1APU	0.76
STA	STATINE	A,I	1GVU	0.76
STA	STATINE	I	3ER5	0.76
STA	STATINE	I	2ER9	0.76
STA	STATINE	E,I	4ER2	0.76
STA	STATINE	A,C,I,J,K	2B7F	0.76
STA	STATINE	A,B,C	5HVP	0.76
STA	STATINE	A,I	1GVV	0.76
STA	STATINE	A,I	1WKR	0.76
STA	STATINE	I	5APR	0.76
STA	STATINE	I	1PSO	0.76
STA	STATINE	I	6APR	0.76
STA	STATINE	A	1FQ5	0.76
STA	STATINE	A,I	3FNT	0.76
STA	STATINE	A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P	3FV3	0.76
STA	STATINE	A,B,C,D,I,J	1LYB	0.76
STA	STATINE	B	1FIV	0.76
STA	STATINE	I	4APR	0.76
CFS	4-AMINO-5-CYCLOHEXYL-2,2-DIFLUORO-3-HYDROXY-PENTANOIC ACID	A	1FQ8	0.71
OCB	OCTANOYLCARNITINE	A,B	1XL8	0.71
SLA	(3S,4R)-3-hydroxy-2-[(1S)-1-hydroxy-2-methylpropyl]-4-methyl-5-oxo-D-proline	H,K,V,Y	3DY4	0.7
CHS	4-AMINO-5-CYCLOHEXYL-3-HYDROXY-PENTANOIC ACID	I	1E80	0.74
CHS	4-AMINO-5-CYCLOHEXYL-3-HYDROXY-PENTANOIC ACID	I	1EED	0.74
CHS	4-AMINO-5-CYCLOHEXYL-3-HYDROXY-PENTANOIC ACID	I	2ER0	0.74
ABW	5-[1-(ACETYLAMINO)-3-METHYLBUTYL]-2,5-ANHYDRO-3,4-DIDEOXY-4-(METHOXYCARBONYL)PENTONIC ACID	A	1XOG	0.72
TMD	(6,7-DIHYDRO)4-[(E)-BUTENYL]-4,N-DIMETHYL-THREONINE	C	1CWK	0.8
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A	3EMY	0.7
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A	2H6T	0.7
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,B	1LS5	0.7
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,B	1SME	0.7
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,C	1W6I	0.7
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,B	1XDH	0.7
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,B	2QZX	0.7
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A	1IZE	0.7
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,B	1M43	0.7
ECQ	(3S)-3-[(2S)-2-AMINO-3-HYDROXYBUTYL]PYRROLIDIN-2-ONE	A,I	2Z3D	0.72
MNL	4,N-DIMETHYLNORLEUCINE	C	1CWC	0.71
OIC	OCTAHYDROINDOLE-2-CARBOXYLIC ACID	B,C	3BV9	0.71
OIC	OCTAHYDROINDOLE-2-CARBOXYLIC ACID	A	1BDK	0.71
SLR	(3R,4R)-3-hydroxy-2-[(1S)-1-hydroxy-2-methylpropyl]-4-methyl-5-oxo-D-proline	K,Y	3DY3	0.7
IVS	3-HYDROXY-6-METHYL-4-(3-METHYL-2-(3-METHYL-2-(3-METHYL-BUTYRYLAMINO)-BUTYRYLAMINO)-BUTYRYLAMINO)-HEPTANOIC ACID ETHYL ESTER	A,B	1ME6	0.74
H5M	TRANS-3-HYDROXY-5-METHYLPROLINE	A,B	1A7Z	0.73
HY3	3-HYDROXYPROLINE	A,B,G	2G66	0.7